< Back to scientific publications

Magazine

UnravellingGeneticMechanisms of Erythrocytosis: A Real-Life Experience from a Single Center

Authors: Carmelo Gurnari,Anna Maria Lombardi,ElisabettaCosi,IdaProvenzano,Maria Teresa Voso

Date: 2018

Scope of interest: Haematology




You may also be interested in:

Report/Poster of Convention/Congress Act

Perampanel as adjunctive therapy in highly refractory epilepsies: Real-word data from an Italian tertiary care epilepsy centre

Authors: A. Morano, J. Fattouch, M. Albini, S. Casciato, M. Fanella, L.M. Basili1 A. Viganò, M. Manfredi, AT. Giallonardo, C. Di Bonaventura

Date: 2019

Scope of interest: Epilepsy


Read details
Report/Poster of Convention/Congress Act

Use of hyperimmune plasma for compassionate use in patients with Marginal Non-Hodgkin Lymphoma persistently positive for SARS-CoV-2 infection

Authors: Cristina D'Amico (1) - Federico De Angelis (1) - Elena Gigliotti (1) - Maria Trimboli (1) - Giorgia Guiducci (1) - Francesca Docimo (1) - Paolo Paesano (1) - Antonietta Arduini (1) - Francesca Chiarlitti (1) - Manuela Alo' (1) - Carla Gargiulo (1)

Date: 2022

Scope of interest: Clinical pathology


Read details
Magazine 11.26

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian‚oRk Study (BRIVAFIRST) Group.

Date: 2022

Scope of interest: Epilepsy


Read details